Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Lutein + Zeaxanthin and Meso-Zeaxanthin are closely matched across evidence, studies, and safety.
Verdict
Likely helps
16 of 17 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
3 of 3 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Lutein + Zeaxanthin and Meso-Zeaxanthin have evidence — compare verdict strength side-by-side.
10mg lutein + 2mg zeaxanthin
With a meal containing fat
Softgels with both lutein and zeaxanthin
10mg daily (often in combination with lutein and zeaxanthin)
With a fat-containing meal, Any time of day
Meso-zeaxanthin with lutein and zeaxanthin (MPOD formula)
3-6 months
4-8 weeks
3-6 months
8-24 weeks
12-24 weeks
Ongoing
The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis
The American journal of clinical nutrition (2016) · Meta analysis · n=387569
Meta-analysis showed a lower risk of coronary heart disease (pooled RR: 0.88; 95% CI: 0.80, 0.98) and stroke (pooled RR: 0.82; 95% CI: 0.72, 0.93) for the highest compared with the lowest tertile of lutein blood concentration or intake.
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration
The Cochrane database of systematic reviews (2023) · Systematic review · n=2445
These studies enroled 11,952 people aged 65 to 75 years and included slightly more women (on average 56% women).
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28
JAMA ophthalmology (2022) · Rct · n=3882
This study included 3882 participants (mean [SD] baseline age, 72.0 [7.7] years; 2240 women [57.7%]) and 6351 eyes.
Effect of Antioxidant Supplementation on Macular Pigment Optical Density and Visual Functions: Network Meta-Analysis
Advances in Nutrition (2024) · Meta analysis · n=3159
Network meta-analysis of RCTs
The Effect of Lutein/Zeaxanthin Intake on Human Macular Pigment Optical Density: A Systematic Review and Meta-Analysis
Advances in Nutrition (2021) · Meta analysis · n=3189
46 studies with 3189 participants analyzed
Carotenoids in the Management of Glaucoma: A Systematic Review of the Evidence
Nutrients (2021) · Systematic review
A comprehensive literature search was conducted in three databases (PubMed, Cochrane Library, and Web of Science) and 20 records were identified for screening.
Based on multiple meta-analyses showing significant MPOD increases in both AMD patients and healthy subjects. Effect size modest but consistent across studies. Higher doses may increase carotenodermia risk.
Based on meta-analysis of 46 studies with 3189 participants confirming dose-response relationship at 5-20mg/day. Effect measured as increase in macular pigment optical density. Conservative estimates given variable individual response rates.
AI-estimated from published studies. Interpret as directional guidance.
Both Lutein + Zeaxanthin and Meso-Zeaxanthin are closely matched — the best choice depends on your specific health goals.
For healthy aging, Lutein + Zeaxanthin has a higher relevance score (95 vs 90).
No known interactions between Lutein + Zeaxanthin and Meso-Zeaxanthin have been documented in our database. However, always consult a healthcare provider before combining supplements.